In the healthcare world, keeping track of product inventory is crucial. But oftentimes, problems arise due to an organization’s disparate systems. When a practice’s systems aren’t linked, staff members may end up wasting time and entering duplicate data.
A new partnership between EHR vendor drchrono and FlexScanMD, an inventory management software company, aims to change that.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
Through the collaboration, FlexScanMD has integrated with drchrono’s EHR system and practice management platform. Therefore, all updates will show up in both FlexScanMD and drchrono. This prevents users from having to manually copy and paste information and double check the data in different systems.
“This partnership will create a seamless and unified workflow that will help make practices more profitable and through error reduction, improve patient outcomes,” Aaron Gerber, FlexScanMD’s director of business development, noted in a news release.
FlexScanMD’s cloud-based platform has a variety of unique components. For example, certain medical practices can use the tool to track profits, commissions and sales on the items they sell.
As drchrono cofounder and COO Daniel Kivatinos said in a statement:
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
The desire to accurately track inventory is growing and is key to improving efficiency among medical practices nationwide. FlexScanMD is a powerful tool with a wide range of features that will enable medical staff to accomplish this. This new integration makes drchrono’s platform an even more versatile and robust system.
In addition to this deal, drchrono has been busy in 2017.
In February, it inked a deal with Physitrack, a telehealth company that supports remote physical therapy monitoring and patient engagement. Physitrack CEO Henrik Molin said Apple’s Mobility Partner Program played a key role in bringing the two organizations together.
In April, the Sunnyvale, California-based startup unveiled a $12 million Series A funding round led by Runa Capital. FundersClub, Maxfield Capital and Quicken CEO Eric Dunn also participated.
Photo: Filograph, Getty Images